A detailed history of Generali Asset Management Spa Sgr transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Generali Asset Management Spa Sgr holds 283,961 shares of BMY stock, worth $15.8 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
283,961
Holding current value
$15.8 Million
% of portfolio
0.41%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$51.92 - $59.94 $14.7 Million - $17 Million
283,961 New
283,961 $16.1 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $118B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Generali Asset Management Spa Sgr Portfolio

Follow Generali Asset Management Spa Sgr and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Generali Asset Management Spa Sgr, based on Form 13F filings with the SEC.

News

Stay updated on Generali Asset Management Spa Sgr with notifications on news.